07:00 , Aug 3, 2015 |  BioCentury  |  Finance

Taiwan's post-bubble prognosis

More than a year after BioCentury chronicled investor enthusiasm for biotechs in Taiwan, the bubble has deflated. It's tempting to blame the downturn simply on retail investors who didn't get up to speed as quickly...
07:00 , May 9, 2011 |  BC Week In Review  |  Financial News

Crown BioScience completes venture financing

Crown BioScience Inc. , Santa Clara, Calif.   Business: Supply/Service   Date completed: 5/4/11   Type: Venture financing   Raised: $28.8 million   Investors: OrbiMed Advisors Caduceus Asia Partners Fund; Argonaut Private Equity; CID Group;...
23:42 , May 4, 2011 |  BC Extra  |  Financial News

Crown raises $28.8 million

CRO Crown Biosciences Inc. (Santa Clara, Calif.) raised $28.8 million in a series C round led by OrbiMed Advisors Caduceus Asia Partners Fund; Argonaut Private Equity; CID Group; IBT; and CDIB Capital Investment. Existing shareholders...
07:00 , Jul 31, 2006 |  BC Week In Review  |  Company News

TransPharma board of directors update

TransPharma Medical Ltd. , Lod, Israel   Business: Drug delivery   Appointed: Jason Martin, a managing director at Argonaut Private Equity  ...
07:00 , Apr 12, 2004 |  BC Extra  |  Financial News

Cetek raises $16 million

High throughput screening company Cetek (Marlborough, Mass.) raised $16 million in a series D round. Investors included John and Stephen Davis; Gainsborough Investments; Argonaut Private Equity; and James Waters. Cetek uses its Natural Product Factory...